East Africa Regional Meeting: Treatment and prevention of malaria in pregnancy in sub-Saharan Africa  
	
  
  11-12 July 2016 - Fairview Hotel - Nairobi, Kenya
For the full meeting report please click here.
Photos from the event can be viewed here.
Welcome and Introductions
Malaria in Pregnancy Consortium:  Overview & Objectives of the Meeting
	Feiko ter Kuile & Jenny Hill. Liverpool School of Tropical Medicine
Burden of Malaria in pregnancy in the East Africa Region
	Patrick Walker Imperial College London - Data not published
Session 1: Use of ACTs for case management of malaria in all trimesters of pregnancy
Safety, efficacy and dosing of ACTs for treatment of clinical malaria in 2nd and 3rd trimesters in Africa
	Michael Nambozi . Tropical Diseases Research Centre (TDRC), Zambia
Safety of ACTs and quinine in early pregnancy in Africa
	Feiko ter Kuile . Liverpool School of Tropical Medicine - Data not published
Knowledge and adherence to national guidelines for malaria case management in pregnancy among health care providers and drug outlets in western Kenya
	Simon Kariuki . Kenya Medical Research Institute (KEMRI)
Session 2: IPTp with 2 vs 3 or more doses of SP and the impact of SP resistance
Effectiveness and cost effectiveness of 2 vs 3+ doses of IPTp with SP
	Feiko ter Kuile . Liverpool School of Tropical Medicine
Impact of SP resistance on the effectiveness of IPTp with SP in sub-Saharan Africa
	Annemieke van Eijk. Liverpool School of Tropical Medicine - Data not published
Effectiveness of antenatal clinics to deliver IPTp-SP in context of other ANC services
	Jenny Hill. Liverpool School of Tropical Medicine
Experiences of implementing current MiP policies - national programme perspectives:
	Peter Njim and Elizabeth Washika. Kenya Ministry of Health, National Malaria Control Programme
	Diana Khonje & Shadreck Mulenga. Malawi Ministry of Health, National Malaria Control Programme
	Baltazar Candrinho. Mozambique Ministry of Health, National Malaria Control Programme
	Victor Chalwe. Zambia Ministry of Health
Session 3: Implications for current policies: Summary and discussion to end day 1
Session 4: Alternative drugs for UPTp and alternative screen and treat approaches (ISTp)
Lessons learnt from IPTp with Mefloquine clinical trials in Benin, Gabon, Kenya, Mozambique and Tanzania
	Raquel Gonzales IS Global   
	Intermittent screening and treatment (ISTp) compared to IPTp-SP in Kenya and Malawi
	Mwayi Madanitsa College of Medicine, Malawi
	User and provider acceptability of alternative drugs for IPTp and ISTp under trial conditions in Ghana, Malawi and Kenya
	Jayne Webster London School of Hygiene and Tropical Medicine - Data not published
Session 5: Implications for national policies and programmes
Potential challenges for MiP policy change and implementation of new policies - national programme perspectives: MOH Representative Thoughts and Presentations
	Peter Njim and Elizabeth Washika Kenya Ministry of Health, National Malaria Control Programme
	Diana Khonje & Shadreck Mulenga Malawi Ministry of Health, National Malaria Control Programme
	Baltazar Candrinho Mozambique Ministry of Health, National Malaria Control Programme
	Georgina Msemo Tanzania Ministry of Health
	Victor Chalwe. Zambia Ministry of Health
 












